C12N 2500/33
Other than alpha-amino carboxylic acids
Official title: other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
C12N2500/33 (Other than alpha-amino carboxylic acids) appears on 90 US grants and 172 published applications in this corpus.
Search patents in C12N- Granted patents
- 90
- Published applications
- 172
- Assignees
- 98
- Inventors
- 343
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 3 |
| 2008 | 1 | 3 |
| 2009 | 0 | 5 |
| 2010 | 2 | 2 |
| 2011 | 0 | 3 |
| 2012 | 0 | 4 |
| 2013 | 3 | 6 |
| 2014 | 0 | 5 |
| 2015 | 5 | 5 |
| 2016 | 5 | 14 |
| 2017 | 6 | 8 |
| 2018 | 7 | 11 |
| 2019 | 7 | 13 |
| 2020 | 6 | 14 |
| 2021 | 4 | 6 |
| 2022 | 10 | 15 |
| 2023 | 3 | 16 |
| 2024 | 5 | 10 |
| 2025 | 8 | 16 |
| 2026 | 10 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Taurine supplemented cell culture medium and methods of use25 Aug 2026US 12,716,051 B2Regeneron Pharmaceuticals, Inc.
- Cell culture media18 Aug 2026US 12,709,733 B2Merck Patent GmbH
- In vitro method of differentiating a human pluripotent stem cell population into a cardiomyocyte cell population11 Aug 2026US 12,703,854 B2Ncardia B.V.
- Method and apparatus for spatial control of cellular growth21 Jul 2026US 12,686,840 B2Research Triangle Institute
- Cell culture compositions with antioxidants and methods for polypeptide production16 Jun 2026US 12,655,385 B2Genentech, Inc.
- Compositions and methods for treatment of spaceflight-associated mitochondrial damage6 Aug 2026US 2026/0224617 A1The Sallie Astor Burdine Breast Foundation
- Stem cell-derived embryo model, and construction method therefor and use thereof16 Jul 2026US 2026/0201321 A1BGI Research Shenzhen
- Culture medium composition9 Jul 2026US 2026/0193602 A1Ajinomoto Co., Inc.
- Method of cell culture9 Jul 2026US 2026/0193614 A1Pfizer Inc.
- Methods and products for transfection30 Apr 2026US 2026/0117193 A1Factor Bioscience Inc.
Most cited
By later US patents
- Culturing human embryonic stem cells in medium containing pipecholic acid and gamma amino butyric acid139US 7,442,548 B2Wisconsin Alumni Research Foundation · 2008
- Hormone-secreting cells maintained in long-term culture29US 5,821,121 APacific Biomedical Research, Inc. · 1998
- Serum-free cell growth medium27US 6,617,161 B2The United States of America as represented by the Department of Health and Human Services · 2003
- Methods of generating natural killer cells23US 8,926,964 B2Anthrogenesis Corporation · 2015
- Production of proteins in glutamine-free cell culture media22US 8,512,983 B22013